Home › Funds › Potomac Capital Management, Inc. › EOLS

Potomac Capital Management, Inc. position in EOLS

EVOLUS INC · Health Care

Potomac Capital Management, Inc. reported holding 141,500 shares of EOLS (EVOLUS INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.98% of its reported portfolio and ranking #29 among its reported holdings. Potomac Capital Management, Inc. has disclosed EOLS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)141.50K sh
Reported value held$1.13M
Portfolio Weight0.98%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Potomac Capital Management, Inc.'s EOLS position evolved

Potomac Capital Management, Inc. first disclosed a stake in EOLS in Q4 2025 at 141,172 shares (US$939K). The position peaked in Q3 2026 at 141,500 shares, worth US$1.1M. Across 4 filings, Potomac Capital Management, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 141,500 shares valued at US$1.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 141.17K $938.79K New
Q1 2026 141.50K $581.57K Hold
Q2 2026 141.50K $982.01K Hold
Q3 2026 141.50K $1.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EOLS and 13F data

EOLS (EVOLUS INC) is a Health Care company. 23 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$50.0M), BRAIDWELL LP (US$21.9M), Frazier Life Sciences Management, L.P. (US$18.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EOLS

All EOLS fund holders →

FAQ

How long has Potomac Capital Management, Inc. held EOLS?

Potomac Capital Management, Inc. has disclosed EOLS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Potomac Capital Management, Inc.'s current position in EOLS?

As of Q3 2026, Potomac Capital Management, Inc. holds 141.50K shares of EOLS (EVOLUS INC), valued at $1.13M, representing 0.98% of its reported portfolio and ranking #29.

Has Potomac Capital Management, Inc. been buying or selling EOLS?

In the latest 13F filing (Q3 2026), Potomac Capital Management, Inc. held unchanged its position in EOLS. The position peaked in Q3 2026 at 141.50K shares.

Which other funds hold EOLS?

Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Frazier Life Sciences Management, L.P., among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.